%0 Journal Article
%T About ATMPs, SOPs and GMP: The Hurdles to Produce Novel Skin Grafts for Clinical Use
%A Daniela Marino
%A Ernst Reichmann
%J Archive of "Transfusion Medicine and Hemotherapy".
%D 2016
%R 10.1159/000447645
%X The treatment of severe full-thickness skin defects represents a significant and common clinical problem worldwide. A bio-engineered autologous skin substitute would significantly reduce the problems observed with today's gold standard
%K Bio-engineered skin grafts
%K ATMP
%K GMP
%K Clinical trials
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073575/